These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38682268)

  • 1. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
    Chen J; Zhang Y; Min H; Zhi J; Ma S; Dong H; Yan J; Chi X; Zhang X; Yang Y
    Helicobacter; 2024; 29(2):e13077. PubMed ID: 38682268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial.
    Zhao JT; Zhang Y; Wang XW; Zou PY; Zhao Z; Mei H; Liu YX; Su NY; Zhu YJ; Wang B; Wei YL; Chen DF; Lan CH
    Helicobacter; 2024; 29(4):e13079. PubMed ID: 38984661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis.
    Wang H; Kong QZ; Li YY; Yang XY; Zuo XL
    J Dig Dis; 2024 Mar; 25(3):163-175. PubMed ID: 38577962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
    Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS;
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):228-241. PubMed ID: 36549320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of
    Zhang C; Zhang J; Cheng YJ
    Saudi J Gastroenterol; 2023; 29(2):88-94. PubMed ID: 36960527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.
    Yang X; Wang JX; Han SX; Gao CP
    Medicine (Baltimore); 2019 Feb; 98(7):e14396. PubMed ID: 30762742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
    Zhou Y; Ye Z; Lu J; Miao S; Lu X; Sun H; Wu J; Wang Y; Huang Y
    Helicobacter; 2020 Oct; 25(5):e12721. PubMed ID: 32656891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
    Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
    Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
    Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
    Nyssen OP; Perez-Aisa A; Rodrigo L; Castro M; Mata Romero P; Ortuño J; Barrio J; Huguet JM; Modollel I; Alcaide N; Lucendo A; Calvet X; Perona M; Gomez B; Gomez Rodriguez BJ; Varela P; Jimenez-Moreno M; Dominguez-Cajal M; Pozzati L; Burgos D; Bujanda L; Hinojosa J; Molina-Infante J; Di Maira T; Ferrer L; Fernández-Salazar L; Figuerola A; Tito L; de la Coba C; Gomez-Camarero J; Fernandez N; Caldas M; Garre A; Resina E; Puig I; O'Morain C; Megraud F; Gisbert JP
    Helicobacter; 2020 Oct; 25(5):e12722. PubMed ID: 32656898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics modulate gastrointestinal microbiota after
    He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
    Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
    Yun JW; Wang C; Yu Y; Xu HM; Gou LZ; Li XL; Yi GR; Lin YM; Han TY; Zhang DK
    Br J Clin Pharmacol; 2023 Jan; 89(1):232-241. PubMed ID: 35947524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
    Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
    Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
    Poonyam P; Chotivitayatarakorn P; Vilaichone RK
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of
    Varga M; Drácz L; Kolbenheyer E; Varga F; Patai ÁV; Solymosi N; Patai Á
    Orv Hetil; 2019 Aug; 160(34):1340-1345. PubMed ID: 31423829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
    Bi H; Chen X; Chen Y; Zhao X; Wang S; Wang J; Lyu T; Han S; Lin T; Li M; Yuan D; Liu J; Shi Y
    Chin Med J (Engl); 2022 Jul; 135(14):1707-1715. PubMed ID: 36193978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metagenomic Changes of Gut Microbiota following Treatment of
    Dore MP; Sau R; Niolu C; Abbondio M; Tanca A; Bibbò S; Loria M; Pes GM; Uzzau S
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Helicobacter pylori and Helicobacter pylori eradication on the microbiota of tongue coating.
    Li C; Qian X; Zhang Z; Jiang Z
    BMC Microbiol; 2024 Oct; 24(1):416. PubMed ID: 39425053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.